Project Grant R01DK148614
Award Date 7/20/26
Completion Date 5/31/30
Dollars Obligated $820K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) was awarded $3,140,632 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a four-year project period from September 1, 2025, through August 31, 2029. This Project Grant supports fundamental biomedical research focused on elucidating the mechanisms of human endocrine lineage commitment...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2,390,830 Project Grant to the University of California, San Francisco (UCSF) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective September 1, 2025, through August 31, 2029. This award funds the development of scalable and transplantable pancreatic islet organoids with engineered oxygenation to improve therapeutic...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The University of Texas Southwestern Medical Center $799,693 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant R01DK147004). The recipient will develop bioengineered pancreatic islet beta cells as a replacement therapy for Type 1 Diabetes. The research optimizes immune-checkpoint-engineered beta cells designed to induce long-term transplant...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Leland Stanford Junior University $5.583 million on July 10, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to analyze immune tolerance mechanisms in Type 1 Diabetes patients receiving sequential B cell depletion and T cell costimulatory blockade therapy. The award funds research analyzing T cell and B cell compartments before and after treatment with sequential...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Regents of the University of California, San Francisco $562,826 on August 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct basic research on irreversible electroporation (IRE)-mediated hepatocyte transplantation as a treatment for inborn errors of metabolism. The research addresses the limited availability of donor organs for liver transplantation by...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Florida $735,969 on August 10, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and test microgels for localized immune control in beta cell replacement therapy for type 1 diabetes. The work combines cell and biomaterials engineering to create stem cell-derived beta cells functionalized with negative regulators of immunity—specifically...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Regents of the University of California, San Francisco $819,556 on August 27, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research investigates the molecular and cellular mechanisms underlying melanocortin-4 receptor (MC4R) activity-dependent trafficking and ciliary localization. MC4R is essential for body weight regulation and represents a...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the Department of Health and Human Services National Institutes of Health, awarded $795,620 to the University of Massachusetts Medical School on July 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds development and validation of gene-editing technologies to engineer stem cell-derived islets for type 1 diabetes treatment. The research...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Cornell University $1,009,332 on September 25, 2025, to develop an immunomodulatory and vascularized cell delivery device for type 1 diabetes cell therapy under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The project aims to engineer a subcutaneous, cell-retaining device that permits blood vessel penetration and establishes an immunotolerant environment for islet delivery in...
- Federal Project Grant Award Summary The University of California, San Francisco received a $3.18 million Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with a completion date of September 14, 2029. This four-year research initiative investigates the role of the macrophage scavenger receptor MARCO (macrophage receptor...